A Closer Look at the New Fluvoxamine Trial Data

Authors of a newly published study on the use of an antidepressant for COVID-19 claim the drug greatly reduces hospitalizations and mortality. But some experts question whether that's really what the data show.

Related Keywords

New York ,United States ,Netherlands ,Utrecht ,London ,City Of ,United Kingdom ,Brazil ,Otavio Berwanger ,Eric Lenze ,Maarten Van Smeden ,Van Smeden ,Angela Reiersen ,James Watson ,King College London ,University Medical Center Utrecht ,Mahidol Oxford Tropical Medicine Research Unit ,Lancet Global Health ,Washington University In St ,Science Media Centre ,Washington University ,Academic Research Organization ,Hospital Israelita Albert Einstein ,Mahidol Oxford Tropical Medicine Research ,College London ,Penny Ward ,New York Timesand ,Science Media ,Saharan Africa ,Lacks Support ,